0000000000235544

AUTHOR

George Kuo

showing 2 related works from this author

Hepatitis C virus replication in ‘autoimmune’ chronic hepatitis

1991

Abstract Both high and low anti-hepatitis C virus antibody (anti-HCV) prevalence has been reported in autoimmune chronic active hepatitis. Therefore, we studied 15 consecutive HBsAg-negative, ELISA anti-HCV-positive, autoantibody-positive patients with biopsy proven chronic active hepatitis in order to confirm ELISA specificity by immunoblot test (RIBA-HCV), and to evaluate HCV replication by serum HCV-RNA. Nine patients were anti-nuclear, three type 1 anti-liver-kidney microsomal and three anti-smooth muscle antibody positive. None had associated autoimmune disease. All cases showed mild clinical disease and only moderate necroinflammatory activity. Response to prednisone was poor. RIBA-HC…

MaleHepatitis C virusMolecular Sequence DataEnzyme-Linked Immunosorbent AssayHepacivirusVirus Replicationmedicine.disease_causePolymerase Chain ReactionVirusHepatitisPrednisoneHumansMedicineHepatitis AntibodiesAutoantibodiesAutoimmune diseaseHepatitisBase SequenceHepatologybiologybusiness.industryChronic ActiveAutoantibodyvirus diseasesHepatitis C AntibodiesMiddle Agedmedicine.diseaseHepatitis Cdigestive system diseasesLiverOligodeoxyribonucleotidesImmunologybiology.proteinRNA ViralFemaleAntibodybusinessmedicine.drugJournal of Hepatology
researchProduct

Prevalence of antibodies to hepatitis C virus among patients with cryptogenic chronic hepatitis and cirrhosis

1992

Many cases of chronic hepatitis and cirrhosis cannot be attributed to a known cause and are collectively referred to as cryptogenic chronic liver disease. We have evaluated the role of the hepatitis C virus in the pathogenesis of this condition in a retrospective serum analysis for antibody to hepatitis C virus in 129 patients with cryptogenic liver disease. Other causes of chronic hepatitis and cirrhosis were ruled out by clinical, serum biochemical and serological techniques. All 129 patients were HBsAg negative, but 28 (22%) had antibody to HBcAg. Sera were tested by radioimmunoassays using recombinant peptides for antibodies to nonstructural (C 100-3 and C33c) and structural regions (C2…

Hepatitismedicine.medical_specialtyCirrhosisHepatologybiologybusiness.industryHepatitis C virusHepatologymedicine.diseaseChronic liver diseasemedicine.disease_causeLiver diseaseHBcAgInternal medicineImmunologymedicinebiology.proteinAntibodybusinessHepatology
researchProduct